Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Mar;117(5):955–961. doi: 10.1111/j.1476-5381.1996.tb15287.x

Influence of monovalent cations on the binding of a charged and an uncharged ('carbo'-)muscarinic antagonist to muscarinic receptors.

X Hou 1, J Wehrle 1, W Menge 1, E Ciccarelli 1, J Wess 1, E Mutschler 1, G Lambrecht 1, H Timmerman 1, M Waelbroeck 1
PMCID: PMC1909415  PMID: 8851517

Abstract

1. The effect of the buffer concentration on binding of [3H]-N-methylscopolamine to muscarinic receptors M2 was tested in rat heart. Tracer binding was of low affinity in a 20 mM imidazole buffer (pKD 8.3), inhibited by an increase from 10 to 100 mM of the sodium phosphate buffer concentration (pKD 9.92 to 9.22), slightly inhibited by an increase of the Tris/HC1 buffer concentration from 20 to 100 mM (pKD 9.70 to 9.47) and unaffected by an increase of the histidine/HC1 buffer concentration from 20 to 100 mM (pKD 9.90 to 9.82). We chose the last buffer to analyse the effect of ions on antagonists binding to cardiac M2 receptors and to transiently expressed wild-type and (Y533-->F) mutant m3 muscarinic receptors in COS-7 cells. 2. Equilibrium [3H]-N-methylscopolamine binding to cardiac M2 receptors was inhibited, apparently competitively, by monovalent salts (LiCl > or = NaCl > or = KCl). In contrast, binding of the uncharged 3,3-dimethylbutan-1-ol ester of diphenylglycolic acid (BS-6181) was facilitated by addition of monovalent salts (LiCl > or = NaCl > or = KCl) to the binding buffer. This cation binding pattern is consistent with interaction with a large, negative field strength binding site, such as, for instance, a carboxylic acid. 3. In the presence of 100 mM NaCl, [3H]-N-methylscopolamine had a similar affinity for the wild-type m3 receptor (pKD 9.85) and for a (Y533-->F) mutant m3 receptor (pKD 9.68). However, in the absence of added salts, the tracer had a significantly lower affinity for the mutated (pKD 10.19) as compared to the wild-type (pKD 10.70) m3 receptor. BS-6181 had a significantly lower affinity for the (Y533-->F) mutant m3 muscarinic receptor, as compared to the wild-type m3 receptor, both in the absence (pKD 6.19-6.72) in the presence (pKD 6.48-7.40) of 100 mM NaCl. The effects of NaCl on binding of the uncharged ester and of [3H]-N-methylscopolamine to the m3 receptor were decreased by the mutation. 4. Taken together, these results support the hypothesis that monovalent cations from the buffer may interact with the cation binding site of the receptors (an aspartate residue in the third transmembrane helix of muscarinic receptors). Buffer cations may inhibit competitively the binding of (charged) muscarinic ligands having a tertiary amine or ammonium group, while facilitating the receptor recognition by uncharged, isosteric 'carbo-analogues'. Mutation of the (Y533-->F) of the m3 receptor decreased the affinity of the receptor for positive charges, including the sodium ion.

Full text

PDF
955

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asselin J., Waelbroeck M., Robberecht P., de Neef P., Christophe J. Effect of pH on binding of agonists and antagonists to rat heart muscarinic receptors. Biochem J. 1983 Oct 15;216(1):11–19. doi: 10.1042/bj2160011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BANISTER J., WHITTAKER V. P. Pharmacological activity of the carbon analogue of acetylcholine. Nature. 1951 Apr 14;167(4250):605–606. doi: 10.1038/167605b0. [DOI] [PubMed] [Google Scholar]
  3. Barlow R. B., Bond S., Holdup D. W., Howard J. A., McQueen D. S., Paterson A., Veale M. A. The contribution of charge to affinity at functional (M3) muscarinic receptors in guinea-pig ileum assessed from the effects of the carbon analogue of 4-DAMP methiodide. Br J Pharmacol. 1992 Aug;106(4):819–822. doi: 10.1111/j.1476-5381.1992.tb14418.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barlow R. B., Chan M. The effects of pH on the affinity of pirenzepine for muscarinic receptors in the guinea-pig ileum and rat fundus strip. Br J Pharmacol. 1982 Nov;77(3):559–563. doi: 10.1111/j.1476-5381.1982.tb09331.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barlow R. B., Tubby J. H. Actions of some esters of 3,3-dimethylbutan-1-ol (the carbon analogue of choline) on the guinea-pig ileum. Br J Pharmacol. 1974 May;51(1):95–100. doi: 10.1111/j.1476-5381.1974.tb09636.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barlow R. B., Winter E. A. Affinities of the protonated and non-protonated forms of hyoscine and hyoscine N-oxide for muscarinic receptors of the guinea-pig ileum and a comparison of their size in solution with that of atropine. Br J Pharmacol. 1981 Apr;72(4):657–664. doi: 10.1111/j.1476-5381.1981.tb09146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Birdsall N. J., Burgen A. S., Hulme E. C., Wells J. W. The effects of ions on the binding of agonists and antagonists to muscarinic receptors. Br J Pharmacol. 1979 Nov;67(3):371–377. doi: 10.1111/j.1476-5381.1979.tb08690.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Birdsall N. J., Chan S. C., Eveleigh P., Hulme E. C., Miller K. W. The modes of binding of ligands to cardiac muscarinic receptors. Trends Pharmacol Sci. 1989 Dec;Suppl:31–34. [PubMed] [Google Scholar]
  9. Bonner T. I. The molecular basis of muscarinic receptor diversity. Trends Neurosci. 1989 Apr;12(4):148–151. doi: 10.1016/0166-2236(89)90054-4. [DOI] [PubMed] [Google Scholar]
  10. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  11. Ehlert F. J., Delen F. M. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats. Mol Pharmacol. 1990 Jul;38(1):143–147. [PubMed] [Google Scholar]
  12. FUNCKE A. B., REKKER R. F., ERNSTING M. J., TERSTEEGE H. M., NAUTA W. T. [Studies on spasmolytics. V. Benzilic acid esters]. Arzneimittelforschung. 1959 Sep;9:573–576. [PubMed] [Google Scholar]
  13. Fraser C. M., Wang C. D., Robinson D. A., Gocayne J. D., Venter J. C. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol Pharmacol. 1989 Dec;36(6):840–847. [PubMed] [Google Scholar]
  14. Hosey M. M. Regulation of antagonist binding to cardiac muscarinic receptors. Biochem Biophys Res Commun. 1982 Jul 16;107(1):314–321. doi: 10.1016/0006-291x(82)91706-5. [DOI] [PubMed] [Google Scholar]
  15. Hosey M. M. Regulation of ligand binding to cardiac muscarinic receptors by ammonium ion and guanine nucleotides. Biochim Biophys Acta. 1983 May 4;757(1):119–127. [PubMed] [Google Scholar]
  16. Hulme E. C., Berrie C. P., Birdsall N. J., Burgen A. S. Two populations of binding sites for muscarinic antagonists in the rat heart. Eur J Pharmacol. 1981 Jul 17;73(2-3):137–142. doi: 10.1016/0014-2999(81)90085-6. [DOI] [PubMed] [Google Scholar]
  17. Hulme E. C., Curtis C. A., Page K. M., Jones P. G. The role of charge interactions in muscarinic agonist binding, and receptor-response coupling. Life Sci. 1995;56(11-12):891–898. doi: 10.1016/0024-3205(95)00025-2. [DOI] [PubMed] [Google Scholar]
  18. Tian W. N., Deth R. C. Precoupling of Gi/G(o)-linked receptors and its allosteric regulation by monovalent cations. Life Sci. 1993;52(24):1899–1907. doi: 10.1016/0024-3205(93)90630-l. [DOI] [PubMed] [Google Scholar]
  19. Waelbroeck M., Camus J., Tastenoy M., Mutschler E., Strohmann C., Tacke R., Lambrecht G., Christophe J. Binding affinities of hexahydro-difenidol and hexahydro-sila-difenidol analogues at four muscarinic receptor subtypes: constitutional and stereochemical aspects. Eur J Pharmacol. 1991 Feb 25;206(2):95–103. doi: 10.1016/0922-4106(91)90017-c. [DOI] [PubMed] [Google Scholar]
  20. Wess J., Gdula D., Brann M. R. Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. EMBO J. 1991 Dec;10(12):3729–3734. doi: 10.1002/j.1460-2075.1991.tb04941.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wess J., Maggio R., Palmer J. R., Vogel Z. Role of conserved threonine and tyrosine residues in acetylcholine binding and muscarinic receptor activation. A study with m3 muscarinic receptor point mutants. J Biol Chem. 1992 Sep 25;267(27):19313–19319. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES